The Medicines Company Mergers and Acquisitions Summary

Life Science Company

The Medicines Company has acquired 6 companies of its own. A total of 3 acquisitions came from private equity firms. It has also divested 2 assets.

The Medicines Company’s largest acquisition to date was in 2013, when it acquired ProFibrix B.V. for $230M. It’s largest disclosed sale occurred in 2017, when it sold The Medicines Company - Infectious Disease Business to Melinta Therapeutics for $270M. The Medicines Company has acquired in 2 different US states, and 3 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).

Join Mergr and gain access to The Medicines Company’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity6
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 5
  • M&A Advisors 5

The Medicines Company

8 Sylvan Way,
Parsippany, New Jersey 07054
United States,
(973) 290-6000
www.themedicinescompany.com

The Medicines Company is a provider of solutions in acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The Medicines Company was formed in 1996 and is based in Parsippany, New Jersey. The Medicines was founded in 1996 and is based in Parsippany, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # 6 - - - - - 6
vol $415M $415M
Sell (0.2/yr) # 1 1 - - - - 2
vol $175M $270M $445M
  8

Most Recent M&A

Company Date Value Type
The Medicines Company - Infectious Disease Business 2017-11-29 270M USD Divestiture
Parsippany, New Jersey
Medicines Company - Hemostasis Products 2015-12-18 175M USD Divestiture
, United States
Annovation BioPharma, Inc. 2015-02-04 - Add-on Acquisition
Cambridge, Massachusetts
Rempex Pharmaceuticals, Inc. 2013-12-04 - Add-on Acquisition
San Diego, California · www.rempexpharma.com
ProFibrix B.V. 2013-06-04 230M USD Add-on Acquisition
Leiden, Netherlands · www.profibrix.com
Incline Therapeutics, Inc. 2013-01-07 185M USD Add-on Acquisition
Redwood City, California
Targanta Therapeutics Corp. 2009-01-13 - Merger
Cambridge, Massachusetts
Curacyte Discovery GmbH 2008-08-04 - Divestiture
Leipzig, Germany
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Incline Therapeutics, Inc.    - ALZA Corp - IONSYS(TM) 2010-06-21 1
Redwood City, California , United States

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 4 (67%) 230M (55%) 2 (100%) 445M (100%)
Medical Products 2 (33%) 185M (45%) - -
Total 6 $415M 2 $445M

By Geo

State/Country Buy Value Sell Value
United States 4 185M 2 445M
  Massachusetts 2 - - -
  California 2 185M - -
  New Jersey - - 1 270M
Germany 1 - - -
Netherlands 1 230M - -
Domestic 4 (67%) 185M (45%) 2 (100%) 445M (100%)
Cross-border 2 (33%) 230M (55%) - -
Total 6 $415M 2 $445M

Top M&A Advisors

Financial Deals
Bank of America Merrill Lynch (BofA Securities)
1
Citigroup Investment Banking
1
J.P. Morgan Securities LLC
1
Legal Deals
Wilmer Cutler Pickering Hale and Dorr LLP
3
Cadwalader, Wickersham & Taft LLP
1

Deal Values

buy # Total
$100M to $1B 2 $415M
TOTAL $415M
Largest ProFibrix B.V.
$230M (2013-06-04)
sell # Total
$100M to $1B 2 $445M
TOTAL $445M
Largest The Medicines Company - Infectious Disease Business
$270M (2017-11-29)

M&A Connections

Deals
Acquired from
Investor(s)
50%
3 (50%)
Strategic(s)
17%
1 (17%)
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 164,188
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 153K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.